[KongchangAI]
ModelAlphaGenome 2

AlphaGenome 2

A genome prediction model released by Google DeepMind. It predicts the effects of DNA sequences and variants on specific human cell types and diseases, focusing on gene regulation and the functional consequences of non-coding variants.

Core Facts

Timeline (last 90 days)

Nov 16

AlphaGenome 2's release announcement appeared on Twitter.

Unverified50%
Nov 16

AlphaGenome 2's announcement did not state whether industry users can obtain access and whether commercial use is restricted.

Unverified50%
Nov 15

Google released AlphaGenome 2 on Wednesday, aimed at disease research.

Unverified50%
Nov 11

AlphaGenome 2 is distributed via API rather than local weights.

Unverified50%
Nov 11

AlphaGenome 2 is provided through the AlphaGenome API and is open for non-commercial research use.

Unverified50%
Nov 11

The AlphaGenome 2 paper found that whether a variant lies in an open chromatin region predicts model performance better than its linear distance to a gene: variants in open regions can be predicted well even when far from genes, whereas variants in compacted regions are predicted poorly.

Unverified50%
Nov 11

In a case involving a locus associated with inflammatory bowel disease, AlphaGenome 2 predicted that a variant regulates a distant gene, and a team at the Crick Institute experimentally validated this prediction.

Unverified50%
Nov 11

Projects such as the Human Cell Atlas have accumulated large amounts of single-cell data, providing cell-type-specific supervision signals for training AlphaGenome 2.

Unverified50%
Nov 11

AlphaGenome 2's differentiated advantage depends on three points: generalization to rare cell types, modeling quality of long-range regulatory interactions, and validation rates in wet-lab experiments.

Unverified50%
Nov 11

AlphaGenome 2 is the successor to the previous-generation model AlphaGenome and is an upgraded version in the AlphaGenome series.

Unverified50%

9 more timeline events

All Facts (19)

Verified

Google DeepMind has launched AlphaGenome Atlas, an AI-powered atlas for predicting the impact of human genome mutations.

65%
Partially Verified

The goal of AlphaGenome 2 is to predict the impact of DNA sequences and their variants on specific human cell types and diseases.

75%
Unverified

AlphaGenome 2's announcement did not state whether industry users can obtain access and whether commercial use is restricted.

50%
Unverified

AlphaGenome 2 is distributed via API rather than local weights.

50%
Unverified

AlphaGenome 2 is provided through the AlphaGenome API and is open for non-commercial research use.

50%
Unverified

The AlphaGenome 2 paper found that whether a variant lies in an open chromatin region predicts model performance better than its linear distance to a gene: variants in open regions can be predicted well even when far from genes, whereas variants in compacted regions are predicted poorly.

50%
Unverified

Projects such as the Human Cell Atlas have accumulated large amounts of single-cell data, providing cell-type-specific supervision signals for training AlphaGenome 2.

50%
Unverified

DeepMind says AlphaGenome 2 is expected to provide clues to disease causes and point to new therapeutic paths.

50%
Unverified

The source material did not disclose AlphaGenome 2's specific performance metrics, the number of cell types covered, or benchmark results.

50%
Unverified

AlphaGenome 2's differentiated advantage depends on three points: generalization to rare cell types, modeling quality of long-range regulatory interactions, and validation rates in wet-lab experiments.

50%
Unverified

A more realistic positioning for AlphaGenome 2 is as an efficient assistant tool for researchers at the hypothesis-generation stage, rather than an endpoint that replaces experiments.

50%
Unverified

AlphaGenome 2 is the successor to the previous-generation model AlphaGenome and is an upgraded version in the AlphaGenome series.

50%
Unverified

AlphaGenome 2's design logic continues the approach of directly predicting molecular phenotypes from genomic sequences, but further refines it to the level of cell-type differences.

50%
Unverified

Officially, only a one-sentence core function description of AlphaGenome 2 has been provided so far, with no disclosure of model architecture, training data scale, evaluation benchmarks or specific performance metrics.

50%
Unverified

Verifiable public details on the prediction accuracy and generalization capability of AlphaGenome 2 are currently still lacking.

50%
Unverified

The core capability of AlphaGenome Atlas comes from DeepMind's AlphaGenome model, which can predict the effects of variants on molecular phenotypes such as gene expression regulation and splicing signals without requiring wet-lab experiments to be performed one by one.

50%
Unverified

AlphaGenome 2's release announcement appeared on Twitter.

50%
Unverified

Google released AlphaGenome 2 on Wednesday, aimed at disease research.

50%
Unverified

In a case involving a locus associated with inflammatory bowel disease, AlphaGenome 2 predicted that a variant regulates a distant gene, and a team at the Crick Institute experimentally validated this prediction.

50%

Source Articles